Helmut
★★★
avatar
Homepage
Vienna, Austria,
2025-11-15 13:36
(200 d 10:25 ago)

Posting: # 24500
Views: 2,250
 

 Visual inspection of fits (estimation of λ-z) [NCA / SHAM]

Dear all,

following the posts in this thread some remarks about automatic algorithms in general. See also there.
  • The selection of the most suitable time interval cannot be left to a programmed algorithm based on mathematical criteria, but necessitates scientific judgment by both the clinical pharmacokineticist and the person who determined the concentrations and knows about their reliability.1
  • It should be emphasised that the TTT method has been introduced in this paper to provide a reasonable tool to support visual curve inspection for reliably identifying the mono-exponential terminal phase. Moreover, the TTT method should not be utilised without visual inspection of the respective concentration-time course. Thus, before using this new approach the monophasic shape post the peak of the curve has to be checked visually by means of a semilogarithmic diagram.2
  • Data must […] always be inspected in order to allow for manual modification of the time interval over which the regression should be made.3
  • It was shown in simulations of two-com­part­ment models that manual selection by a pharmacokineticist outperforms standard automatic methods.4 Our brain is an excellent pattern rec­og­​ni­tion machine.
  • Using this methodology, Phoenix will almost always compute an estimate for Lambda Z. It is the user’s responsibility to evaluate the appropriateness of the estimated value.5

  1. Hauschke D, Steinijans VW, Pigeot I. Bioequivalence Studies in Drug Development: Methods and Applications. New York: Wiley; 2007. p. 20-3.
  2. Scheerans C, Derendorf H, Kloft C. Proposal for a Standardised Identification of the Mono-Exponential Terminal Phase for Orally Administered Drugs. Biopharm Drug Dispos. 2008; 29(3): 145–57. doi:10.1002/bdd.596.
  3. Källén A. Computational Pharmacokinetics. Boca Raton: Chapman & Hall/CRC; 2008. p. 43
  4. Noe DA. Performance characteristics of the adjusted r2 algorithm for determining the start of the terminal disposition phase and comparison with a simple r2 algorithm and a visual inspection method. Pharm Stat. 2019; 1–13. doi:10.1002/pst.1979.
  5. Certara USA, Inc. Princeton, NJ. 7/9/20. Lambda Z or Slope Estimation settings. Online.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
ElMaestro
★★★

Denmark,
2025-11-15 20:10
(200 d 03:52 ago)

@ Helmut
Posting: # 24501
Views: 1,906
 

 Visual inspection of fits (estimation of λ-z)

❝   — Our brain is an excellent pattern rec­og­​ni­tion machine.


... and this widely recognised fact also explains why regulators over the years have been so happy to see manual integration in chromatography. :-D

Pass or fail!
ElMaestro
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2025-11-16 10:21
(199 d 13:40 ago)

@ ElMaestro
Posting: # 24502
Views: 1,903
 

 Wetware 🧠 vs. software 🤖

Hi ElMaestro,

❝ ❝   — Our brain is an excellent pattern rec­og­​ni­tion machine.

❝ ... and this widely recognised fact also explains why regulators over the years have been so happy to see manual integration in chromatography. :-D


… though they realized that sometimes it still is necessary (ICH M10 Section 3.3.6). Yep, has to be documented.

There is an invited comment about the comparison of r2 and visual inspection (reference #4 of the post above). Since it is behind a paywall, important parts:

The implementation of the algorithm in WinNonlin (which is essentially unchanged today) is an aid to provide an initial estimate for the user who can then manually adjust the terminal slope calculation for each individual as appropriate. It was realized at the time of the original development that the adjusted r2 approach might not always select the same time points that a user would select by visual inspection, which is precisely why an interactive graphical tool was included with WinNonlin. In this sense, the adjusted r2 algorithm was simply an aid to increase efficiency of the analysis of pharmacokinetic data. Over almost 30 years, the adjusted r2 algorithm as implemented has been unchanged, and we are not aware of any alternative algorithms that would significantly improve the accuracy or speed of the estimation method. However, we agree with the author that for some profiles the adjusted r2 algorithm appears to have some bias, and we would welcome suggestions on either how to identify profiles the adjusted r2 algorithm may not perform well on, improve the adjusted r2 algorithm to decrease the bias, or propose an alternative algorithm that is more accurate and equally as efficient.
[…]
An important operational point to note is that the time required for analysis is an important consideration in use of any algorithm. The r2 and adjusted r2 algorithms take a fraction of a second to implement for a single pharmacokinetic profile. The time required to implement the visual inspection algorithm proposed by the author is not stated; however, one can assume that it might be approximately 60 seconds for a single pharmacokinetic profile. This suggests that the visual inspection algorithm is at least 60-fold less efficient than either the r2 or adjusted r2 algorithms. Even if one accepts the author’s assertion that the visual inspection algorithm has less bias across all pharmacokinetic data analysts, the enormous loss of efficiency for a small (<10%) improvement in bias would argue that the visual inspection algorithm is not an improvement over either the r2 or adjusted r2 algorithms.

(my emphases).

IMHO, this line of argument is convoluted. r2 was developed as a tool to get initial estimates. Since it is known to be imperfect, the user can (and should according to WinNonlin’s User’s Guide) make adjustments. So far, so good. This is exactly what I do for ages as well.
But then the authors speak of ’efficiency’ (speed?). Oh dear, 60 seconds per profile? 🧠💤
Further, with my 30+ years of experience with the software I can say that the algo works remarkably well for IR and DR formulations. Sometimes I have to exclude an increasing last concentration. Remember that at the LLOQ A&P can be 20%. Therefore, an apparent increase might be pure chance. However, not excluding it, would bias λz with all of its ugly consequence (larger extrapolated AUC).
For formulations with flat profiles (CR, patches, etc) the algo fails quite often. The authors prefer not to talk about that.



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Ohlbe
★★★

France,
2025-11-17 09:32
(198 d 14:29 ago)

@ ElMaestro
Posting: # 24503
Views: 1,825
 

 Manual integrations

Dear ElMaestro,

[OffTopic]

❝ ❝   — Our brain is an excellent pattern rec­og­​ni­tion machine.


❝ ... and this widely recognised fact also explains why regulators over the years have been so happy to see manual integration in chromatography. :-D


Well, you have to acknowledge that some labs gave them excellent reasons for that reaction... Where inspectors' brains recognised patterns of biased integrations to validate failed runs. As usual, some people f*cked up, and the rest of the profession is now paying the price for it.

I have on my computer the slides of an old presentation from Sciex in 2003, comparing manual integrations and the 3 integration algorithms in Analyst 1.4 (Analyst Classic, MQII, IQA) using artificial (synthetic) chromatograms, which concluded that:
- Human integration performs better than any of the machine algorithms
- All algorithms provide consistency, human eye is not as consistent.

It also showed that Analyst Classic performed the worst on most tested aspects (except for the integration of split peaks). Interesting, considering the very, very large number of labs using it.

[/OffTopic]

Regards
Ohlbe
ElMaestro
★★★

Denmark,
2025-11-17 10:35
(198 d 13:26 ago)

@ Ohlbe
Posting: # 24504
Views: 1,849
 

 Manual int

"We can only hope that CROs and companies would employ a higher degree of manual integration to QCs and calibrators due to the superior performance of the human eye", said John McMuffin-Scrotum, vice director at OGD (Office of Gonococcal Drugs) at a conference in Bethesda last Thursday, and continued: "It has been shown beyond reasonable doubt that no algorithm outperforms the human eye. Software limitations can not and should never prevent patients from having access to affordable alternatives to expensive branded drugs."

Pass or fail!
ElMaestro
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
373 visitors (0 registered, 373 guests [including 30 identified bots]).
Forum time: 01:02 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5